Rchr
J-GLOBAL ID:201901005200040780   Update date: Oct. 06, 2024

Ohashi Ayaka

オオハシ アヤカ | Ohashi Ayaka
Affiliation and department:
Job title: Assistant Professor
Research field  (2): Immunology ,  Hematology and oncology
Research theme for competitive and other funds  (6):
  • 2023 - 2026 慢性活動性Epstein-Barrウイルス病新規治療標的分子の同定と治療薬開発
  • 2020 - 2022 慢性活動性EBウイルス感染症における血管障害発症機構の解明と治療法の開発
  • 2022 - Treatment development of refractory EBV-related disease eradication targeting EBNA-1 to banish EBV
  • 2019 - 2020 CAEBVにおけるEBウイルス由来RNAの解析:発症への関与と治療標的の可能性
  • 2016 - 2018 腫瘍および血管内皮細胞におけるRNase inhibitorの発現と分泌
Show all
Papers (13):
  • Ayaka Ohashi, Masanori A. Murayama, Yoshishige Miyabe, Kazuo Yudoh, Chie Miyabe. Streptococcal infection and autoimmune diseases. Frontiers in Immunology. 2024. 15
  • Miwako Nishio, Minori Saito, Mayumi Yoshimori, Yuki Kumaki, Ayaka Ohashi, Eri Susaki, Ichiro Yonese, Megumi Sawada, Ayako Arai. Clinical significance of anti-Epstein-Barr virus antibodies in systemic chronic active Epstein-Barr virus disease. Frontiers in Microbiology. 2024. 14
  • Yu Uemura, Kumi Oshima, Aika Fuseya, Akane Hosokai, Ayaka Ohashi, Masatoshi Kanno, Ayako Arai. Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collection. International Journal of Hematology. 2023. 118. 6. 772-775
  • Yu Uemura, Ayaka Ohashi, Mayumi Yoshimori, Miwako Nishio, Tsuneaki Hirakawa, Norio Shimizu, Naomi Wada, Ken-Ichi Imadome, Ayako Arai. Plasma interferon-γ concentration: a potential biomarker of disease activity of systemic chronic active Epstein-Barr virus infection. Frontiers in Virology. 2022. 2
  • Ayaka Ohashi, Yu Uemura, Mayumi Yoshimori, Naomi Wada, Ken-Ichi Imadome, Kazuo Yudo, Takatoshi Koyama, Norio Shimizu, Miwako Nishio, Ayako Arai. The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein-Barr Virus Infection. Frontiers in Microbiology. 2022. 13
more...
MISC (1):
  • 内田 晶子, 上村 悠, 平川 経晃, 大橋 彩香, 吉森 真由美, 小島 茂樹, 櫻田 勉, 新井 文子. HLHに伴う高サイトカイン血症に対するPEとCHDFの効果(Blood purification therapy on hypercytokinemia caused by hemophagocytic lymphohistiocytosis). 日本血液学会学術集会. 2021. 83回. OS3-1
Patents (1):
  • 慢性活動性Epatein-Barrウイルス感染症(CAEBV)の検出方法
Books (1):
  • 日本臨牀増刊「新リンパ腫学」
    日本臨牀社 2023
Lectures and oral presentations  (23):
  • BCL2 and BCL-xL inhibitors combat both tumor and inflammation of chronic active EBV infection
    (2022)
  • The Effects of BCL2 Inhibitors on Chronic Active EBV Infections, an Intractable T- or NK-cell Lymphoid Neoplasm
    (2022)
  • HLA 半合致同種造血幹細胞移植症後の;Human herpesvirus;型脳症
    (第35回ヘルペスウイルス研究会 2022)
  • 慢性活動性Eウイルス感染症における血清中抗体価の検討
    (第35回ヘルペスウイルス研究会 2022)
  • HLA半合致末梢血幹細胞移植を行った慢性活動性EBウイルス感染症
    (第44回日本造血・免疫細胞療法学会総会 2022)
more...
Education (4):
  • 2016 - 2019 Tokyo Medical and Dental University
  • 2016 - 2018 Justus-Liebig University Department of Biochemistry, Faculty of Medicine
  • 2014 - 2016 Tokyo Medical and Dental University
  • 2010 - 2014 Tokyo Medical and Dental University Faculty of Medicine
Professional career (1):
  • 博士(保健学) (東京医科歯科大学)
Work history (3):
  • 2023/04 - 現在 St.Marianna University School of Medicine Department of Immunology and Parasitology assistant professor
  • 2020/03 - 2023/03 St.Marianna University School of Medicine
  • 2019/04 - 2020/02 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences
Awards (3):
  • 2023 - St. Marianna University School of Medicine St. Marianna University School of Medicine Award in Recognition of Academic Work Promoting Diversity (2023)
  • 2022/11 - St. Marianna University School of Medicine Maeda Prize
  • 2014/03 - 中谷・椎名学術奨励賞
Association Membership(s) (1):
日本臨床衛生検査技師会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page